These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mood disorders: pharmacologic prevention of recurrences. National Institutes of Health Consensus Development Conference Statement. Natl Inst Health Consens Dev Conf Consens Statement; 1984; 5(4):8 p.. PubMed ID: 6398407 [No Abstract] [Full Text] [Related]
10. The use of lithium in mixed states. Sani G; Fiorillo A CNS Spectr; 2020 Aug; 25(4):449-451. PubMed ID: 31248464 [TBL] [Abstract][Full Text] [Related]
11. Manic symptoms following addition of lithium to antidepressant treatment. Price LH; Charney DS; Heninger GR J Clin Psychopharmacol; 1984 Dec; 4(6):361-2. PubMed ID: 6512008 [No Abstract] [Full Text] [Related]
12. Lithium and relapse prevention in manic-depressive illness. Schou M Psychosomatics; 1983 Jun; 24(6):533-5, 537, 540-1. PubMed ID: 6136064 [No Abstract] [Full Text] [Related]
13. [New developments in preventive therapy of manic-depressive disease]. Schou M Psychiatr Neurol Med Psychol Beih; 1988; 41():60-3. PubMed ID: 3151400 [No Abstract] [Full Text] [Related]
14. Lithium update: causes of and remedies for incomplete response to lithium. Schou M Adv Biochem Psychopharmacol; 1984; 39():413-20. PubMed ID: 6464832 [No Abstract] [Full Text] [Related]
15. [Depressed patients in daily practice. 2: Drug treatment in depression]. Jänicke U Z Arztl Fortbild (Jena); 1991 May; 85(10):484-6. PubMed ID: 1858398 [No Abstract] [Full Text] [Related]
16. [Response to antidepressive drugs: a useful trait marker for genetic characterization of depressed patients?]. Canceil O Encephale; 1995 Dec; 21 Spec No 4():61-3. PubMed ID: 8808349 [No Abstract] [Full Text] [Related]